PExA AB (publ)
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrum… Read more
PExA AB (publ) (FA0) - Total Assets
Latest total assets as of September 2025: €11.84 Million EUR
Based on the latest financial reports, PExA AB (publ) (FA0) holds total assets worth €11.84 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PExA AB (publ) - Total Assets Trend (2021–2024)
This chart illustrates how PExA AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PExA AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
PExA AB (publ)'s total assets of €11.84 Million consist of 91.0% current assets and 9.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 54.9% |
| Accounts Receivable | €548.15K | 5.4% |
| Inventory | €2.42 Million | 23.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how PExA AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PExA AB (publ)'s current assets represent 91.0% of total assets in 2024, a decrease from 94.3% in 2021.
- Cash Position: Cash and equivalents constituted 54.9% of total assets in 2024, down from 78.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 23.8% of total assets.
PExA AB (publ) Competitors by Total Assets
Key competitors of PExA AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
PExA AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PExA AB (publ) generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PExA AB (publ) is currently not profitable relative to its asset base.
PExA AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.15 | 8.05 | 8.05 |
| Quick Ratio | 4.24 | 5.98 | 5.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €8.60 Million | € 10.35 Million | € 10.35 Million |
PExA AB (publ) - Advanced Valuation Insights
This section examines the relationship between PExA AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | -32.7% |
| Total Assets | €10.19 Million |
| Market Capitalization | $2.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values PExA AB (publ)'s assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: PExA AB (publ)'s assets decreased by 32.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for PExA AB (publ) (2021–2024)
The table below shows the annual total assets of PExA AB (publ) from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €10.19 Million | -32.72% |
| 2023-12-31 | €15.14 Million | -39.17% |
| 2022-12-31 | €24.89 Million | -5.40% |
| 2021-12-31 | €26.31 Million | -- |